Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

McGill University

$105,000.00

Promoting Responsible Governance of Mitochondrial Replacement Therapy in Canada.

FY 2017-18

Summary
Mitochondrial diseases are a group of rare inherited disorders that can be present at birth or manifest later in life. They cause devastating physical, developmental, and cognitive impairments that are progressive and have no available cure. The number of people affected with mitochondrial diseases is difficult to assess, since the range of conditions is wide and have diverse symptoms. Mitochondrial Replacement Therapy (MRT) is a type of in vitro fertilization (IVF) that aims to prevent the transmission of mitochondrial diseases to next generations. As mitochondrial DNA is passed down from the maternal line, MRT replaces a mother's mutated mitochondrial DNA with mitochondria from a healthy egg donor. MRT in Canada is considered a criminal offence by the Assisted Human Reproduction Act (2004), which prohibits any practice that modifies the genome of a human being or in vitro embryo. In order to provide Canadian policymakers with informed policy options for the rapidly evolving context of assisted reproductive technologies, I will conduct a systematic literature review of relevant academic sources which characterize the socio-ethical implications and scientific advancements of MRT. I will also review and assess pertinent legislation, policies, and ethical guidelines, in both the research and clinical contexts, in Canada, the US, the UK, and Mexico. Based on the knowledge obtained from the two aforementioned steps, I will interview Canadian stakeholders (scientists, clinicians, policymakers, ethicists, couples with affected children as well as those who are carriers and wish to have biological children and egg donors) with regard to MRT in order to seek a more thorough perspective of their needs and worries. Finally, I will analyze my results by applying an ethics of care theory in order to produce key policy principles to help bioethicists and regulatory bodies alike develop policies better suited to the Canadian health care context.
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
383376
Name
Noohi Forough
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Doctoral Research Awards - B
Projecttitle
Promoting Responsible Governance of Mitochondrial Replacement Therapy in Canada.
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Bioethics; Canadian Healthcare; Ethics Of Care; Gene Therapy; Genome Editing; Health Policy; Human Genetics; Mitochondrial Replacement Therapy; Science Policy
Abstract
Mitochondrial diseases are a group of rare inherited disorders that can be present at birth or manifest later in life. They cause devastating physical, developmental, and cognitive impairments that are progressive and have no available cure. The number of people affected with mitochondrial diseases is difficult to assess, since the range of conditions is wide and have diverse symptoms. Mitochondrial Replacement Therapy (MRT) is a type of in vitro fertilization (IVF) that aims to prevent the transmission of mitochondrial diseases to next generations. As mitochondrial DNA is passed down from the maternal line, MRT replaces a mother's mutated mitochondrial DNA with mitochondria from a healthy egg donor. MRT in Canada is considered a criminal offence by the Assisted Human Reproduction Act (2004), which prohibits any practice that modifies the genome of a human being or in vitro embryo. In order to provide Canadian policymakers with informed policy options for the rapidly evolving context of assisted reproductive technologies, I will conduct a systematic literature review of relevant academic sources which characterize the socio-ethical implications and scientific advancements of MRT. I will also review and assess pertinent legislation, policies, and ethical guidelines, in both the research and clinical contexts, in Canada, the US, the UK, and Mexico. Based on the knowledge obtained from the two aforementioned steps, I will interview Canadian stakeholders (scientists, clinicians, policymakers, ethicists, couples with affected children as well as those who are carriers and wish to have biological children and egg donors) with regard to MRT in order to seek a more thorough perspective of their needs and worries. Finally, I will analyze my results by applying an ethics of care theory in order to produce key policy principles to help bioethicists and regulatory bodies alike develop policies better suited to the Canadian health care context.
Competitiondate
201710
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Noohi, Forough
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~
McGill University - $105,000 Grant (2017-18) | Canada Spends